FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 90 filers reported holding FATE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $249,677 | -58.7% | 24,745 | -8.3% | 0.00% | -100.0% |
| Q3 2022 | $605,000 | -18.1% | 26,984 | -9.5% | 0.00% | 0.0% |
| Q2 2022 | $739,000 | -35.2% | 29,815 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $1,141,000 | -5.5% | 29,436 | +42.6% | 0.00% | 0.0% |
| Q4 2021 | $1,208,000 | -0.1% | 20,646 | +1.2% | 0.00% | 0.0% |
| Q3 2021 | $1,209,000 | -30.5% | 20,396 | +1.8% | 0.00% | -50.0% |
| Q2 2021 | $1,739,000 | +5.3% | 20,041 | +0.1% | 0.00% | 0.0% |
| Q1 2021 | $1,651,000 | -20.9% | 20,025 | -12.8% | 0.00% | 0.0% |
| Q4 2020 | $2,088,000 | +155.9% | 22,959 | +12.4% | 0.00% | +100.0% |
| Q3 2020 | $816,000 | +11.3% | 20,425 | -4.3% | 0.00% | 0.0% |
| Q2 2020 | $733,000 | +48.4% | 21,350 | -4.0% | 0.00% | 0.0% |
| Q1 2020 | $494,000 | -26.3% | 22,250 | -35.0% | 0.00% | 0.0% |
| Q4 2019 | $670,000 | +6.7% | 34,247 | -15.3% | 0.00% | 0.0% |
| Q3 2019 | $628,000 | -10.7% | 40,457 | +16.8% | 0.00% | 0.0% |
| Q2 2019 | $703,000 | +22.9% | 34,638 | +6.4% | 0.00% | 0.0% |
| Q1 2019 | $572,000 | +62.5% | 32,548 | +18.6% | 0.00% | 0.0% |
| Q4 2018 | $352,000 | -26.2% | 27,438 | -6.3% | 0.00% | 0.0% |
| Q3 2018 | $477,000 | +54.9% | 29,288 | +7.7% | 0.00% | 0.0% |
| Q2 2018 | $308,000 | +18.0% | 27,203 | +1.7% | 0.00% | – |
| Q1 2018 | $261,000 | +85.1% | 26,750 | +16.2% | 0.00% | – |
| Q4 2017 | $141,000 | – | 23,025 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |